Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

FHS
July 24, 2024
10:40 am

Broken String Biosciences (“Broken String”), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has appointed Steve Becker as Chief Commercial Officer.

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

June 20, 2023

The latest twist in John Green’s anti-tuberculosis story: working with governments

WASHINGTON — John Green, the popular novelist and YouTube star, gave the health care world a taste of his clout last year when he and

March 16, 2024

U.S. Drops Virus-Hunting Program; Spicy Chip and Fatality; Lost Bladder Tumor

Note that some links may require registration or subscription. The United States Agency for International Development quietly dropped a flagship project for hunting viruses among

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.